ASHLAND INC.
Business
Ashland Inc. is a global additives and specialty ingredients company serving consumer and industrial markets including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company provides excipients, polymers, thickeners, stabilizers, preservatives, rheology modifiers, and chemical intermediates through four reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Ashland operates manufacturing and distribution facilities across the Americas, Europe, the Middle East, Africa, and Asia Pacific, serving customers in more than 100 countries.
Summary from 10-K filed 2025-11-20
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Sales - Note P | 1,824 | 2,113 | 2,191 | 2,391 | 2,111 | |
| Cost of sales - Note Q | 1,275 | 1,495 | 1,523 | 1,561 | 1,441 | |
| Gross profit | 549 | 618 | 668 | 830 | 670 | |
| Selling, general and administrative expense - Note Q | 344 | 404 | 365 | 393 | 358 | |
| Research and development expense | 54 | 55 | 51 | 55 | 50 | |
| Intangibles amortization expense - Note G | 63 | 76 | 93 | 94 | 90 | |
| Equity and other income | 4 | 6 | 7 | 3 | 9 | |
| Goodwill impairment - Note G | 706 | 0 | 0 | 0 | 0 | |
| Income (loss) on acquisitions and divestitures, net - Note B | −161 | −115 | 6 | 42 | 11 | |
| Operating income (loss) | −775 | −26 | 172 | 333 | 192 | |
| Net interest and other expense (income) - Note H | 33 | −24 | 6 | 149 | 56 | |
| Other net periodic benefit loss - Note L | 1 | 22 | 6 | −22 | −1 | |
| Income (loss) from continuing operations before income taxes | −809 | −24 | 160 | 206 | 135 | |
| Income tax expense (benefit) - Note K | 13 | −223 | −8 | 25 | −38 | |
| Income (loss) from continuing operations | −822 | 199 | 168 | 181 | 173 | |
| Income (loss) from discontinued operations, net of income taxes - Note C | −23 | −30 | 10 | 746 | 47 | |
| Net income (loss) | −845 | 169 | 178 | 927 | 220 | |
| Income (loss) from continuing operations | −17.74 | 3.99 | 3.18 | 3.26 | 2.85 | |
| Income (loss) from discontinued operations | −0.49 | −0.59 | 0.18 | 13.45 | 0.78 | |
| Net income (loss) (per share) | −18.23 | 3.4 | 3.36 | 16.71 | 3.63 | |
| Income (loss) from continuing operations | −17.74 | 3.95 | 3.13 | 3.2 | 2.82 | |
| Income (loss) from discontinued operations | −0.49 | −0.59 | 0.18 | 13.21 | 0.77 | |
| Net income (loss) (per share) | −18.23 | 3.36 | 3.31 | 16.41 | 3.59 | |
| Unrealized translation gain | 45 | 54 | 72 | −197 | 7 | |
| Unrealized gain (loss) on commodity hedges | 2 | 1 | −6 | −1 | 4 | |
| Other comprehensive income | 47 | 55 | 66 | −197 | 11 | |
| Comprehensive income (loss) | −798 | 224 | 244 | 730 | 231 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 215 | 300 | 417 | 646 | 210 | |
| Accounts receivable, net - Notes A and H | 242 | 243 | 338 | 402 | 369 | |
| Inventories - Note A | 568 | 545 | 626 | 629 | 473 | |
| Other assets | 180 | 107 | 125 | 91 | 68 | |
| Total current assets | 1,205 | 1,195 | 1,506 | 1,768 | 1,717 | |
| Cost | 3,355 | 3,316 | 3,211 | 3,050 | 3,066 | |
| Accumulated depreciation | 2,154 | 2,013 | 1,838 | 1,712 | 1,639 | |
| Net property, plant and equipment | 1,201 | 1,303 | 1,373 | 1,338 | 1,427 | |
| Goodwill - Note G | 705 | 1,381 | 1,362 | 1,312 | 1,430 | |
| Intangibles - Note G | 563 | 751 | 886 | 963 | 1,099 | |
| Operating lease assets, net - Note J | 103 | 114 | 122 | 107 | 124 | |
| Restricted investments - Note E | 297 | 295 | 290 | 313 | 384 | |
| Asbestos insurance receivable, net - Notes A and M | 127 | 132 | 127 | 138 | 134 | |
| Deferred income taxes - Note K | 157 | 210 | 22 | 20 | 30 | |
| Other assets - Note I | 253 | 264 | 251 | 254 | 267 | |
| Total noncurrent assets | 3,406 | 4,450 | 4,433 | 4,445 | 4,895 | |
| Total assets | 4,611 | 5,645 | 5,939 | 6,213 | 6,612 | |
| Trade and other payables | 189 | 214 | 210 | 265 | 236 | |
| Accrued expenses and other liabilities | 213 | 256 | 208 | 269 | 251 | |
| Current operating lease obligations - Note J | 21 | 20 | 22 | 19 | 23 | |
| Total current liabilities | 423 | 490 | 456 | 553 | 934 | |
| Long-term debt - Note H | 1,384 | 1,349 | 1,314 | 1,270 | 1,596 | |
| Asbestos litigation reserves - Note M | 389 | 414 | 427 | 472 | 490 | |
| Deferred income taxes - Note K | 31 | 29 | 148 | 176 | 237 | |
| Employee benefit obligations - Note L | 96 | 110 | 100 | 103 | 144 | |
| Operating lease obligations - Note J | 85 | 99 | 106 | 94 | 110 | |
| Other liabilities - Note I | 299 | 286 | 291 | 325 | 349 | |
| Total noncurrent liabilities | 2,284 | 2,287 | 2,386 | 2,440 | 2,926 | |
| Commitments and contingencies - Notes J and M | — | — | — | — | — | |
| Common stock, par value $.01 per share, 200 million shares authorized Issued 46 million and 47 million shares in 2025 and 2024 | 1 | 1 | 1 | 1 | 1 | |
| Paid-in capital | 6 | — | 4 | 135 | 327 | |
| Retained earnings | 2,298 | 3,315 | 3,595 | 3,653 | 2,796 | |
| Accumulated other comprehensive loss | −401 | −448 | −503 | −569 | −372 | |
| Total equity | 1,904 | 2,868 | 3,097 | 3,220 | 2,752 | |
| Total liabilities and equity | 4,611 | 5,645 | 5,939 | 6,213 | 6,612 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 237 | 274 | 243 | 241 | 244 | |
| Original issue discount and debt issuance cost amortization | 7 | 6 | 6 | 7 | 7 | |
| Deferred income taxes | 73 | −302 | −32 | −35 | −26 | |
| Gain from sales of property and equipment | −16 | 0 | −1 | 0 | −4 | |
| Stock based compensation expense - Note O | 14 | 15 | 22 | 18 | 15 | |
| Benefit (loss) from excess tax deduction on stock based compensation | −3 | 0 | 2 | — | — | |
| Income from restricted investments | −33 | −74 | −43 | 86 | −33 | |
| Loss (income) on acquisitions and divestitures, net - Notes B | 177 | 107 | −7 | −42 | −15 | |
| Asset impairments | 0 | 11 | 4 | — | — | |
| Pension contributions | −12 | −15 | −8 | −5 | −8 | |
| Loss (gain) on pension and other postretirement plan remeasurements | −3 | 14 | −2 | −22 | 1 | |
| Change in operating assets and liabilities | −191 | 227 | −58 | −237 | 80 | |
| Total cash flows provided by operating activities from continuing operations | 134 | 462 | 294 | 193 | 466 | |
| Additions to property, plant and equipment | −98 | −137 | −170 | −113 | −105 | |
| Proceeds from disposal of property, plant and equipment | 16 | 0 | 11 | 51 | 5 | |
| Proceeds from sale or restructuring of operations | 16 | 26 | 0 | 0 | 14 | |
| Proceeds from settlement of company-owned life insurance contracts | 12 | 1 | 6 | 3 | 91 | |
| Company-owned life insurance payments | −5 | −5 | −5 | −4 | −6 | |
| Funds restricted for specific transactions | −8 | −5 | −9 | −74 | −91 | |
| Reimbursement from restricted investments | 62 | 79 | 58 | 35 | 33 | |
| Proceeds from sale of securities | 56 | 53 | 47 | 87 | 149 | |
| Purchase of securities | −54 | −53 | −47 | −87 | −149 | |
| Other investing cash flows | 0 | −10 | 0 | 0 | — | |
| Total cash flows used by investing activities from continuing operations | −3 | −51 | −109 | — | — | |
| Proceeds from (repayment of) short-term debt | 0 | −16 | 16 | −365 | 84 | |
| Repurchase of common stock | −100 | −380 | −300 | −200 | −450 | |
| Cash dividends paid | −76 | −78 | −76 | −70 | −70 | |
| Stock based compensation employee withholding taxes paid in cash | −3 | −5 | −11 | −9 | −7 | |
| Total cash flows used by financing activities from continuing operations | −179 | −479 | −371 | −896 | −426 | |
| CASH USED BY CONTINUING OPERATIONS | −48 | −68 | −186 | −805 | −327 | |
| Operating cash flows | −40 | −51 | −51 | −406 | 94 | |
| Total cash used by discontinued operations | −40 | −51 | −51 | 1,252 | 80 | |
| Effect of currency exchange rate changes on cash and cash equivalents | 3 | 2 | 8 | −11 | 3 | |
| DECREASE IN CASH AND CASH EQUIVALENTS | −85 | −117 | −229 | 436 | −244 | |
| Accounts receivable | −3 | 96 | 58 | −23 | 72 | |
| Inventories | −28 | 79 | −7 | −141 | 41 | |
| Trade and other payables | −63 | 56 | −112 | 34 | 3 | |
| Other assets and liabilities | −97 | −4 | 3 | −107 | −36 | |
| Interest paid | 54 | 52 | 53 | 56 | 62 | |
| Income taxes paid (including discontinued operations) | 33 | 53 | 63 | 406 | 1 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is ASHLAND INC.'s CIK number?
ASHLAND INC.'s SEC CIK number is 0001674862 (1674862). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find ASHLAND INC.'s SEC filings?
All of ASHLAND INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did ASHLAND INC. last report earnings?
ASHLAND INC. (ASH) most recently filed an earnings 8-K with the SEC on Apr 28, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-187700). This is ASHLAND INC.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is ASHLAND INC.'s most recent earnings 8-K?
ASHLAND INC.'s latest earnings 8-K (Item 2.02) was filed Apr 28, 2026 under accession 0001193125-26-187700. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View ASHLAND INC.'s latest earnings 8-K →
Look up any company's CIK number →